BlackRock’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9,903
| Closed | -$103K | – | 5552 |
|
|
2023
Q3 | $103K | Sell |
9,903
-14
| -0.1% | -$110 | ﹤0.01% | 4834 |
|
|
2023
Q2 | $54.1K | Sell |
9,917
-2,060
| -17% | -$19.3K | ﹤0.01% | 5049 |
|
|
2023
Q1 | $144K | Buy |
11,977
+66
| +0.6% | +$880 | ﹤0.01% | 4877 |
|
|
2022
Q4 | $97.5K | Buy |
11,911
+45
| +0.4% | +$1.17K | ﹤0.01% | 5051 |
|
|
2022
Q3 | $507K | Sell |
11,866
-56
| -0.5% | -$2.98K | ﹤0.01% | 4727 |
|
|
2022
Q2 | $606K | Buy |
11,922
+81
| +0.7% | +$3.98K | ﹤0.01% | 4710 |
|
|
2022
Q1 | $761K | Sell |
11,841
-99
| -0.8% | -$4.94K | ﹤0.01% | 4758 |
|
|
2021
Q4 | $625K | Buy |
11,940
+93
| +0.8% | +$6.53K | ﹤0.01% | 4811 |
|
|
2021
Q3 | $883K | Sell |
11,847
-44
| -0.4% | -$3.77K | ﹤0.01% | 4593 |
|
|
2021
Q2 | $1.19M | Sell |
11,891
-29,748
| -71% | -$2.95M | ﹤0.01% | 4460 |
|
|
2021
Q1 | $4.96M | Buy |
41,639
+857
| +2% | +$121K | ﹤0.01% | 3945 |
|
|
2020
Q4 | $5.29M | Buy |
40,782
+1,668
| +4% | +$214K | ﹤0.01% | 3685 |
|
|
2020
Q3 | $4.52M | Buy |
39,114
+8,651
| +28% | +$1.07M | ﹤0.01% | 3621 |
|
|
2020
Q2 | $4.21M | Buy |
30,463
+16,804
| +123% | +$2.06M | ﹤0.01% | 3591 |
|
|
2020
Q1 | $1.17M | Buy |
13,659
+1,733
| +15% | +$178K | ﹤0.01% | 3828 |
|
|
2019
Q4 | $1.2M | Buy |
11,926
+8,673
| +267% | +$953K | ﹤0.01% | 3951 |
|
|
2019
Q3 | $460K | Buy |
3,253
+385
| +13% | +$71.3K | ﹤0.01% | 4191 |
|
|
2019
Q2 | $667K | Buy |
+2,868
| New | +$908K | ﹤0.01% | 4126 |
|
Other funds holding AXLA
BlackRock's AXLA Position: Q4 2023 in Review
BlackRock sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 9,903 shares — an estimated $103K sold.
BlackRock first reported a position in AXLA in Q2 2019 and held it in 18 quarters. The position peaked at $5.29M in Q4 2020. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- BlackRock reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- BlackRock sold 9,903 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $103K.
- BlackRock first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- BlackRock's Axcella Health Inc. Common Stock position peaked at $5.29M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.